Please login to the form below

Not currently logged in
Email:
Password:

aHUS

This page shows the latest aHUS news and features for those working in and with pharma, biotech and healthcare.

Alexion uses priority review voucher for Soliris follow-up

Alexion uses priority review voucher for Soliris follow-up

Ravulizumab is also in late-stage testing for patients with PNH who have been treated with Soliris, as well as those with a typical haemolytic uremic syndrome (aHUS), another rare and

Latest news

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • NICE and ‘ultra orphans’ NICE and ‘ultra orphans’

    There are currently around 140 people diagnosed with aHUS in England, but and at least another 140 people are estimated to have the condition but be undiagnosed. ... The drug had been assessed in aHUS by AGNSS, which was convinced of its clinical

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics